semaglutide after kidney transplant FDA Approves Ozempic for Disease & Type 2 Diabetes Semaglutide: A Breakthrough for Chronic

GLP-1 (glucagon-like peptide-1) is one of these hormones and improves insulin function to lower blood sugar levels and delays gastric emptying, decreasing appetite

Disturbi gastrici, indigestione

This highlights the importance of managing common side effects like vomiting and diarrhea before they lead to secondary issues

Conversely, medications that further slow gastric emptying, such as anticholinergics or opioid analgesics, may exacerbate gastrointestinal adverse effects including nausea, vomiting, and constipation

"Semaglutide wont be available to everyone," Helen Knight, director of medicines evaluation at NICE, said in March